Enanta Pharmaceuticals
ENTA
ENTA
111 hedge funds and large institutions have $408M invested in Enanta Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
61% less call options, than puts
Call options by funds: $638K | Put options by funds: $1.62M
Holders
111
Holding in Top 10
3
Calls
$638K
Puts
$1.62M
Top Buyers
| 1 | +$12.4M | |
| 2 | +$12.3M | |
| 3 | +$7.63M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$4.89M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$4.4M |
Top Sellers
| 1 | -$51M | |
| 2 | -$2.39M | |
| 3 | -$2.38M | |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$2.36M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$1.61M |